| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology and Genetics |
Unit of Cell and Molecular Biology, Dental School, University of Dundee, Dundee, United Kingdom
Requests for reprints: Seth L. Schor, Unit of Cell and Molecular Biology, Dental School, University of Dundee, Dundee DD1 4HR, United Kingdom. Phone: 44-1382-635991; Fax: 44-1382-635998; E-mail: S.L.Schor{at}dundee.ac.uk.
Migration stimulating factor (MSF) is a truncated oncofetal fibronectin isoform expressed by fetal and tumor-associated cells. MSF mRNA is distinguished from other fibronectin isoforms by its size (2.1 kb) and the inclusion of a specific intronic sequence at its 3' end. Initial Northern blot analysis with a MSF-specific probe indicated the presence of this 2.1-kb transcript and an additional unexpected 5.9-kb RNA present in both MSF-secreting (fetal) and nonsecreting (adult) fibroblasts. Our investigations into the nature of these transcripts and their relationship to MSF protein secretion revealed that the 5.9-kb mRNA is a second MSF-encoding transcript. Both these mRNAs have identical coding sequence and differ only in the length of their intron-derived 3'-untranslated region (UTR). The 5.9-kb MSF mRNA is retained in the nucleus whereas the 2.1-kb mRNA is not. MSF-secreting fetal fibroblasts have significantly lower nuclear levels of the 5.9-kb mRNA and correspondingly higher cytoplasmic levels of the 2.1-kb transcript than their nonsecreting adult counterparts. Adult fibroblasts induced to secrete MSF by treatment with transforming growth factor-ß1 displayed similar changes in their respective levels of MSF mRNA, but not those of a control gene. When cloned downstream of a reporter gene, only the longer 3'-UTR retained coding sequence within the nucleus. We conclude that expression of MSF protein is regulated by 3'-UTR truncation of the 5.9-kb nuclear-sequestered "precursor" MSF mRNA and nuclear export of mature 2.1-kb message. Inducible 3'-UTR processing represents a novel regulatory mechanism involved in cancer pathogenesis that may open new avenues for therapeutic gene delivery.
This article has been cited by other articles:
![]() |
C. S. Bond and A. H. Fox Paraspeckles: nuclear bodies built on long noncoding RNA J. Cell Biol., September 7, 2009; 186(5): 637 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hu, Y. Ran, Y. Zhang, Z. Zhou, S. J. Harris, L. Yu, L. Sun, J. Pan, J. Liu, J. Lou, et al. Antibody Library-based Tumor Endothelial Cells Surface Proteomic Functional Screen Reveals Migration-stimulating Factor as an Anti-angiogenic Target Mol. Cell. Proteomics, April 1, 2009; 8(4): 816 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Terry, E. B. Shows, and S. R. Wente Crossing the Nuclear Envelope: Hierarchical Regulation of Nucleocytoplasmic Transport Science, November 30, 2007; 318(5855): 1412 - 1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. V. Prasanth and D. L. Spector Eukaryotic regulatory RNAs: an answer to the 'genome complexity' conundrum Genes & Dev., January 1, 2007; 21(1): 11 - 42. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |